Assessment of regulatory needs list
Assessment of regulatory needs list
The assessment of regulatory needs list includes substances for which an assessment either is under development or has been completed.
For each substance, the table shows the assessing authority (submitter), the concern, the status and the suggested follow-up action, and the date of the latest update to the list entry.
Other process details and relevant documents are also available and can be accessed through the ‘Details’ icon for the list entry.
Regulatory Management Option Analysis (RMOA) are assessments of regulatory needs. Publication of RMOA was initiated in February 2013 with the start of the implementation of the SVHC Roadmap. In 2019, authorities and in particular ECHA have moved to address more groups of substances.
The responsibility for the content of an assessment of regulatory needs rests with the authority that developed it. It is possible that other authorities do not have the same view and may develop a further assessment of regulatory needs for the same (group of) substances. Assessment of regulatory needs and their conclusions are compiled based on available information and may change in light of new information or further assessment.
Last updated 03 May 2024. Database contains 5017 unique substances/entries.
Filter the list
The List does not contain any Substances.
|
229-745-1
|
6701-13-9
|
ECHA
|
Under development
|
CCH Other action |
08-Jul-2021
|
Details | ||
|
300-723-4
|
127823-21-6
|
ECHA
|
Under development
|
Other action
|
08-Jul-2021
|
Details | ||
|
255-901-3
|
42594-17-2
|
ECHA
|
Under development
|
CCH Other action |
08-Jul-2021
|
Details | ||
|
256-062-6
|
43048-08-4
|
ECHA
|
Under development
|
CCH Other action |
08-Jul-2021
|
Details | ||
|
256-032-2
|
42978-66-5
|
ECHA
|
Under development
|
Other action
|
08-Jul-2021
|
Details | ||
|
204-112-2
|
115-86-6
|
France
|
Endocrine disruption Skin sensitiser |
Concluded
|
Other
|
10-Sep-2019
|
Details | |
|
202-924-1
|
101-20-2
|
France
|
Endocrine disruption |
Concluded
|
Other
|
09-Aug-2018
|
Details | |
|
203-625-9
|
108-88-3
|
Netherlands
|
Carcinogenic Mutagenic Toxic for reproduction |
Concluded
|
Other
|
13-Jul-2020
|
Details | |
|
260-830-6
|
57583-54-7
|
France
|
Endocrine disruption |
Concluded
|
Other
|
10-Aug-2018
|
Details | |
|
238-877-9
|
14807-96-6
|
Netherlands
|
Carcinogenic STOT RE |
Concluded
|
CLH Other |
10-Dec-2021
|
Details | |
|
215-185-5
|
1310-73-2
|
Sweden
|
Other human toxicity |
Concluded
|
Other
|
08-Apr-2015
|
Details | |
|
215-181-3
|
1310-58-3
|
Sweden
|
Other human toxicity |
Concluded
|
Other
|
08-Apr-2015
|
Details | |
|
231-106-7
|
7439-97-6
|
Denmark
|
Carcinogenic Mutagenic Toxic for reproduction |
Concluded
|
Other
|
23-Sep-2014
|
Details | |
|
610-589-1
|
50926-11-9
|
Netherlands
|
Other environmental toxicity Other human toxicity Toxic for reproduction |
Concluded
|
Other
|
13-Oct-2018
|
Details | |
|
204-260-8
|
118-56-9
|
France
|
Endocrine disruption Respiratory sensitiser Skin sensitiser |
Concluded
|
Other
|
27-Mar-2019
|
Details | |
|
258-649-2
|
53585-53-8
|
Finland
|
Bioaccumulation Other environmental toxicity Persistence |
Concluded
|
Other
|
24-Feb-2020
|
Details | |
|
231-150-7
|
7440-41-7
|
Germany
|
Carcinogenic Mutagenic Toxic for reproduction |
Concluded
|
Other
|
19-Dec-2016
|
Details | |
|
232-565-6
|
9000-90-2
|
United Kingdom
|
Respiratory sensitiser Skin sensitiser |
Concluded
|
Other
|
17-Jul-2018
|
Details | |
|
250-863-4
|
31906-04-4
|
Sweden
|
Skin sensitiser |
Concluded
|
Other
|
05-Jun-2015
|
Details | |
|
690-137-8
|
5436-43-1
|
France
|
Endocrine disruption |
Concluded
|
Other
|
30-Jan-2019
|
Details | |
|
214-946-9
|
1222-05-5
|
France
|
Endocrine disruption |
Concluded
|
Other
|
22-Jan-2020
|
Details | |
|
400-370-7
|
6196-98-1
|
Finland
|
Bioaccumulation Other environmental toxicity Persistence |
Concluded
|
Other
|
24-Feb-2020
|
Details | |
|
203-293-5
|
105-38-4
|
Sweden
|
Carcinogenic Mutagenic |
Concluded
|
None
|
11-Dec-2020
|
Details | |
|
203-545-4
|
108-05-4
|
Sweden
|
Carcinogenic Mutagenic |
Concluded
|
None
|
11-Dec-2020
|
Details | |
|
225-768-6
|
5064-31-3
|
Denmark
|
Carcinogenic Mutagenic Toxic for reproduction |
Concluded
|
None
|
23-Sep-2014
|
Details | |
|
234-829-6
|
12035-72-2
|
Hungary
|
Carcinogenic Mutagenic Skin sensitiser Toxic for reproduction |
Concluded
|
None
|
12-May-2017
|
Details | |
|
201-067-0
|
77-90-7
|
France
|
Endocrine disruption |
Concluded
|
None
|
07-Nov-2016
|
Details | |
|
203-625-9
|
108-88-3
|
Denmark
|
Mutagenic Toxic for reproduction Widespread use |
Concluded
|
None
|
12-Jan-2017
|
Details | |
|
202-830-0
|
100-21-0
|
France
|
Endocrine disruption |
Concluded
|
None
|
07-Mar-2017
|
Details | |
|
911-915-8
|
-
|
Ireland
|
Bioaccumulation Carcinogenic Endocrine disruption Mutagenic Persistence Respiratory sensitiser STOT RE Skin sensitiser Toxic for reproduction |
Concluded
|
None
|
05-Jul-2023
|
Details | |
|
202-051-6
|
91-22-5
|
Ireland
|
Carcinogenic Mutagenic Toxic for reproduction |
Concluded
|
None
|
10-Jul-2015
|
Details | |
|
272-234-3
|
68784-26-9
|
Sweden
|
Toxic for reproduction |
Concluded
|
None
|
28-Nov-2018
|
Details | |
|
272-233-8
|
68784-25-8
|
Sweden
|
Mutagenic Toxic for reproduction |
Concluded
|
None
|
28-Nov-2018
|
Details | |
|
272-486-4
|
68855-45-8
|
Sweden
|
Toxic for reproduction |
Concluded
|
None
|
28-Nov-2018
|
Details | |
|
229-891-6
|
6818-37-7
|
Ireland
|
Bioaccumulation Carcinogenic Endocrine disruption Mutagenic Persistence Respiratory sensitiser STOT RE Skin sensitiser Toxic for reproduction |
Concluded
|
None
|
05-Jul-2023
|
Details | |
|
227-534-9
|
5873-54-1
|
Denmark
|
Respiratory sensitiser Skin sensitiser Toxic for reproduction |
Concluded
|
None
|
23-Sep-2014
|
Details | |
|
240-841-2
|
16812-54-7
|
Germany
|
Carcinogenic Mutagenic Toxic for reproduction |
Concluded
|
None
|
12-May-2017
|
Details | |
|
629-719-3
|
1219010-04-4
|
Sweden
|
STOT RE |
Concluded
|
None
|
16-Apr-2019
|
Details | |
|
679-769-5
|
2675-94-7
|
Sweden
|
Carcinogenic Mutagenic |
Concluded
|
None
|
25-Aug-2021
|
Details | |
|
215-204-7
|
1313-27-5
|
Denmark
|
Carcinogenic Mutagenic Persistence Toxic for reproduction |
Concluded
|
None
|
01-Dec-2020
|
Details | |
|
247-714-0
|
26447-40-5
|
Denmark
|
Carcinogenic Mutagenic Skin sensitiser Toxic for reproduction |
Concluded
|
None
|
23-Sep-2014
|
Details | |
|
200-659-6
|
67-56-1
|
Denmark
|
Carcinogenic Mutagenic Toxic for reproduction |
Concluded
|
None
|
08-Jul-2016
|
Details | |
|
231-106-7
|
7439-97-6
|
Sweden
|
Other human toxicity STOT RE Toxic for reproduction |
Concluded
|
None
|
09-Feb-2018
|
Details | |
|
203-615-4
|
108-78-1
|
France
|
Endocrine disruption |
Concluded
|
None
|
29-Apr-2024
|
Details | |
|
232-089-9
|
7785-87-7
|
Denmark
|
Carcinogenic Endocrine disruption Mutagenic Toxic for reproduction |
Concluded
|
None
|
12-Jan-2017
|
Details | |
|
247-722-4
|
26471-62-5
|
Denmark
|
Carcinogenic Mutagenic Skin sensitiser Toxic for reproduction |
Concluded
|
None
|
23-Sep-2014
|
Details | |
|
200-579-1
|
64-18-6
|
Bulgaria
|
Bioaccumulation Endocrine disruption Other human toxicity Persistence |
Concluded
|
None
|
05-Jul-2017
|
Details | |
|
629-757-0
|
1224966-15-7
|
Netherlands
|
Other environmental toxicity Other human toxicity |
Concluded
|
None
|
05-Jul-2017
|
Details | |
|
291-275-8
|
90367-27-4
|
Ireland
|
Bioaccumulation Carcinogenic Endocrine disruption Mutagenic Persistence Respiratory sensitiser STOT RE Skin sensitiser Toxic for reproduction |
Concluded
|
None
|
05-Jul-2023
|
Details | |
|
291-269-5
|
90367-21-8
|
Ireland
|
Bioaccumulation Carcinogenic Endocrine disruption Mutagenic Persistence Respiratory sensitiser STOT RE Skin sensitiser Toxic for reproduction |
Concluded
|
None
|
05-Jul-2023
|
Details | |